Protect Pharmaceutical Corporation
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name… Read more
Protect Pharmaceutical Corporation (PRTT) - Net Assets
Latest net assets as of June 2025: $345.88 Million USD
Based on the latest financial reports, Protect Pharmaceutical Corporation (PRTT) has net assets worth $345.88 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($423.30 Million) and total liabilities ($77.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $345.88 Million |
| % of Total Assets | 81.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | 5548.68% |
| 10-Year Change | N/A |
| Growth Volatility | 2990.75 |
Protect Pharmaceutical Corporation - Net Assets Trend (2011–2024)
This chart illustrates how Protect Pharmaceutical Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Protect Pharmaceutical Corporation (2011–2024)
The table below shows the annual net assets of Protect Pharmaceutical Corporation from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $332.69 Million | +20.38% |
| 2023-12-31 | $276.36 Million | +20.17% |
| 2022-12-31 | $229.98 Million | +11.84% |
| 2021-12-31 | $205.64 Million | +3391.53% |
| 2020-12-31 | $5.89 Million | +7586.36% |
| 2019-12-31 | $76.62K | +252.67% |
| 2018-12-31 | $-50.19K | +65.01% |
| 2017-12-31 | $-143.44K | -588.63% |
| 2016-12-31 | $-20.83K | +79.26% |
| 2015-12-31 | $-100.45K | +16.97% |
| 2014-12-31 | $-120.98K | +79.67% |
| 2013-12-31 | $-595.13K | -3.11% |
| 2012-12-31 | $-577.19K | -35.63% |
| 2011-12-31 | $-425.56K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Protect Pharmaceutical Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 32671659600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $325.94 Million | 97.97% |
| Common Stock | $5.75 Million | 1.73% |
| Other Components | $1.00 Million | 0.30% |
| Total Equity | $332.69 Million | 100.00% |
Protect Pharmaceutical Corporation Competitors by Market Cap
The table below lists competitors of Protect Pharmaceutical Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CATENON SA INH. EO-02
F:8Y9
|
$8.62 Million |
|
BLUE STAR GOLD
F:5WP0
|
$8.62 Million |
|
Tiny Ltd.
PINK:TNYZF
|
$8.63 Million |
|
Ayalon Holdings Ltd
TA:AYAL
|
$8.63 Million |
|
Acceleware Ltd
PINK:ACWRF
|
$8.62 Million |
|
Lippo General Insurance Tbk
JK:LPGI
|
$8.61 Million |
|
Canaf Investments Inc
PINK:CAFZF
|
$8.61 Million |
|
Keyware Technologies NV
BR:KEYW
|
$8.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Protect Pharmaceutical Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 276,362,000 to 332,689,000, a change of 56,327,000 (20.4%).
- Net income of 56,327,000 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $56.33 Million | +16.93% |
| Total Change | $- | 20.38% |
Book Value vs Market Value Analysis
This analysis compares Protect Pharmaceutical Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.22x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $-0.16 | $1.30 | x |
| 2010-12-31 | $-11.28 | $1.30 | x |
| 2011-12-31 | $-9.70 | $1.30 | x |
| 2012-12-31 | $-12.95 | $1.30 | x |
| 2013-12-31 | $-13.35 | $1.30 | x |
| 2014-12-31 | $-2.24 | $1.30 | x |
| 2015-12-31 | $-0.23 | $1.30 | x |
| 2016-12-31 | $-0.02 | $1.30 | x |
| 2017-12-31 | $-0.13 | $1.30 | x |
| 2019-12-31 | $0.00 | $1.30 | x |
| 2020-12-31 | $0.11 | $1.30 | x |
| 2021-12-31 | $3.66 | $1.30 | x |
| 2022-12-31 | $4.36 | $1.30 | x |
| 2023-12-31 | $4.81 | $1.30 | x |
| 2024-12-31 | $5.79 | $1.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Protect Pharmaceutical Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.93%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 42.59%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.26x
- Recent ROE (16.93%) is above the historical average (10.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.63K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.98 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-227.44K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-496.58K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $35.57K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $470.24K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-624.96K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.62K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-108.27K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $3.55K |
| 2020 | 98.70% | 97.85% | 0.30x | 3.40x | $5.22 Million |
| 2021 | 9.83% | 25.65% | 0.22x | 1.78x | $-356.00K |
| 2022 | 9.76% | 27.44% | 0.24x | 1.50x | $-556.30K |
| 2023 | 16.61% | 33.72% | 0.37x | 1.33x | $18.28 Million |
| 2024 | 16.93% | 42.59% | 0.32x | 1.26x | $23.06 Million |
Industry Comparison
This section compares Protect Pharmaceutical Corporation's net assets metrics with peer companies in the Integrated Freight & Logistics industry.
Industry Context
- Industry: Integrated Freight & Logistics
- Average net assets among peers: $368,651,163
- Average return on equity (ROE) among peers: 13.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Protect Pharmaceutical Corporation (PRTT) | $345.88 Million | 0.00% | 0.22x | $8.62 Million |
| Andlauer Healthcare Group Inc (ANDHF) | $352.12 Million | 25.55% | 0.83x | $469.38 Million |
| Aqua Power Systems Inc (APSI) | $-106.64K | 0.00% | 0.00x | $383.65K |
| A-Sonic Aerospace Limited (ASNCF) | $38.42 Million | 0.28% | 1.15x | $7.03 Million |
| Addentax Group Corp (ATXG) | $86.00K | 65.43% | 97.87x | $2.89 Million |
| bpost SA/NV (BPOSF) | $682.60 Million | 22.59% | 4.53x | $472.00 Million |
| Armlogi Holding Corp. Common Stock (BTOC) | $25.09 Million | -61.17% | 5.78x | $4.28 Million |
| Compañía de Distribución Integral Logista Holdings S.A (CDNIF) | $641.80 Million | 48.03% | 11.59x | $1.70 Billion |
| Cargojet Inc (CGJTF) | $66.60 Million | 3.60% | 5.94x | $791.09 Million |
| CH Robinson Worldwide Inc (CHRW) | $1.88 Billion | 26.94% | 1.74x | $20.09 Billion |
| Tianci International, Inc. Common Stock (CIIT) | $-32.66K | 0.00% | 0.00x | $14.82 Million |